latest news releases from the newsroom
Volvo Invitation to Press and Teleconference
GOTEBORG, Sweden, Oct. 14, 2005 (PRIMEZONE) -- Volvo hereby invites the media to a press conference on Tuesday, October 25 in conjunction with the release of the Volvo Group's report on the third quarter 2005.
Elekta Carries Outs 3:1 Share Split
STOCKHOLM, Sweden, Oct. 14, 2005 (PRIMEZONE) -- In accordance with a decision at the Annual General Meeting, effective Monday October 17, 2005, the Elekta share will be traded following a 3:1 split.
Volvo to Sell Celero Support Service Company
GOTEBORG, Sweden, Oct. 14, 2005 (PRIMEZONE) -- AB Volvo is selling the Group's service company Celero Support AB to Coor Service Management for SEK 680 M less the company's net debt, which currently amounts to approx SEK 130 M. The sale will result in a capital gain for Volvo of about SEK 450 M.
Galapagos Featured in Leading Drug Discovery Journal
MECHELEN, Belgium, Oct. 14, 2005 (PRIMEZONE) -- Galapagos NV, a genomics-based drug discovery company, announces that an article presenting the Company's approach to target discovery will appear in the October 15, 2005 issue of Drug Discovery Today, a top-ranking review journal in the field of drug discovery research. The paper, entitled "Biology calls the targets: combining RNAi and disease biology", gives insight into how Galapagos applies its proprietary RNA interference (RNAi) technology. Furthermore, the article explains how this biology-driven approach can be used to functionally validate drug targets for major human diseases."Galapagos has built extensive expertise in using RNAi to discover and validate novel drug targets in a wide range of disease areas. Our scientists were invited to present our protein knock-down technology using adenovirus-based RNAi libraries to discover new targets in human primary cells," said Onno van de Stolpe, CEO of Galapagos. "There is particularly strong interest in RNAi in the pharmaceutical industry and we believe targets identified using our approach could improve overall success rates in the drug discovery process. The confidence is underscored by the fact that our pharmaceutical partners have taken targets identified using this biology-driven strategy, forward into their internal drug discovery programs."
SAS Technical Services Takes Off with Intentia
STOCKHOLM, Sweden, Oct. 14, 2005 (PRIMEZONE) -- Intentia International AB (publ) (XSSE:INT B), the global enterprise provider for the manufacturing, distribution and maintenance industries announces that SAS Technical Services is investing in Intentia Application Suite in order to further reinforce the company's position as a leading supplier of overall solutions for maintenance and the provision of spare parts to global airline companies.
Occidental Petroleum Corp.
Occidental To Discuss Vintage Acquisition In Conference Call
LOS ANGELES, Oct. 13, 2005 (PRIMEZONE) -- Occidental Petroleum Corporation (NYSE:OXY) will hold a conference call on Friday, October 14, 2005, to discuss its acquisition of Vintage Petroleum. The conference call, which will begin at 6:00 a.m. Pacific, may be accessed by calling 1-888-873-8496. The conference call also can be heard live on the company's website, www.oxy.com.
Occidental Petroleum Corp.
Occidental Agrees to Acquire Vintage Petroleum
LOS ANGELES, Oct. 13, 2005 (PRIMEZONE) -- Occidental Petroleum Corporation (NYSE:OXY) announced today it has agreed to acquire, by means of a merger, Vintage Petroleum, Inc. (NYSE:VPI) for $20.00 per Vintage share in cash, plus 0.42 Occidental shares per Vintage share. The total purchase consideration for Vintage's approximately 68.3 million shares on a fully diluted basis, including debt assumption net of cash, is approximately $3.8 billion. As part of this transaction, Oxy plans to implement a stock re-purchase program for 9 million Oxy shares in the open market or otherwise, from time-to-time, subject to market conditions and retention of the company's credit rating.